Highlights
NASDAQ: AKBA       Akebia Therapeutics
Last Price Today's Change   Day's Range   Trading Volume
3.06   -0.11 (3.47%)  3.06 - 3.25  2,995,600

Overview

 
Avg Volume (4 weeks):4,509,194
4 Weeks Range:2.96 - 3.70
4 Weeks Price Volatility (%):
13.51%
52 Weeks Range:2.09 - 13.71
52 Weeks Price Volatility (%):
8.35%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Its lead product candidate is vadadustat, an oral therapy, which is used for the treatment of anemia related to chronic kidney disease in non-dialysis and dialysis patients. The company is also developing a HIF-based portfolio of product for the treatment of anemia. Geographically, all the business activity is functioned through the region of United States.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

5321  4267  669  146 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 NAKD 0.637-0.083 
 CTRM 0.508-0.025 
 SNDL 1.000.00 
 AAPL 132.99+3.19 
 FUBO 23.31+1.15 
 AFMD 9.74-0.53 
 SQQQ 11.07-0.35 
 NIO 38.12-0.23 
 TENX 2.08-0.01 
 GE 13.60+0.10